BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16257382)

  • 1. Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma.
    Tai CK; Wang WJ; Chen TC; Kasahara N
    Mol Ther; 2005 Nov; 12(5):842-51. PubMed ID: 16257382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of replication-competent retroviral vectors in an immunocompetent intracranial glioma model.
    Wang W; Tai CK; Kershaw AD; Solly SK; Klatzmann D; Kasahara N; Chen TC
    Neurosurg Focus; 2006 Apr; 20(4):E25. PubMed ID: 16709031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model.
    Chen SH; Sun JM; Chen BM; Lin SC; Chang HF; Collins S; Chang D; Wu SF; Lu YC; Wang W; Chen TC; Kasahara N; Wang HE; Tai CK
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors.
    Wang WJ; Tai CK; Kasahara N; Chen TC
    Hum Gene Ther; 2003 Jan; 14(2):117-27. PubMed ID: 12614563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of replication-competent retrovirus vector-mediated suicide gene therapy in a multifocal colorectal cancer metastasis model.
    Hiraoka K; Kimura T; Logg CR; Tai CK; Haga K; Lawson GW; Kasahara N
    Cancer Res; 2007 Jun; 67(11):5345-53. PubMed ID: 17545615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma.
    Kawasaki Y; Tamamoto A; Takagi-Kimura M; Maeyama Y; Yamaoka N; Terada N; Okamura H; Kasahara N; Kubo S
    Cancer Gene Ther; 2011 Aug; 18(8):571-8. PubMed ID: 21660062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly efficient gene transfer to solid tumors in vivo by tumor-selective replicating retrovirus vectors.
    Lu YC; Luo YP; Wang YW; Tai CK
    Int J Mol Med; 2010 May; 25(5):769-75. PubMed ID: 20372821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene.
    Tai CK; Wang W; Lai YH; Logg CR; Parker WB; Li YF; Hong JS; Sorscher EJ; Chen TC; Kasahara N
    Cancer Gene Ther; 2010 Sep; 17(9):614-23. PubMed ID: 20467451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
    Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral replicating vector-mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity.
    Hiraoka K; Inagaki A; Kato Y; Huang TT; Mitchell LA; Kamijima S; Takahashi M; Matsumoto H; Hacke K; Kruse CA; Ostertag D; Robbins JM; Gruber HE; Jolly DJ; Kasahara N
    Neuro Oncol; 2017 Jul; 19(7):918-929. PubMed ID: 28387831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of preclinical in vivo models for the assessment of replicating retroviral vectors for the treatment of glioblastoma.
    Hlavaty J; Jandl G; Liszt M; Petznek H; König-Schuster M; Sedlak J; Egerbacher M; Weissenberger J; Salmons B; Günzburg WH; Renner M
    J Neurooncol; 2011 Mar; 102(1):59-69. PubMed ID: 20623247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous administration of retroviral replicating vector, Toca 511, demonstrates therapeutic efficacy in orthotopic immune-competent mouse glioma model.
    Huang TT; Parab S; Burnett R; Diago O; Ostertag D; Hofman FM; Espinoza FL; Martin B; Ibañez CE; Kasahara N; Gruber HE; Pertschuk D; Jolly DJ; Robbins JM
    Hum Gene Ther; 2015 Feb; 26(2):82-93. PubMed ID: 25419577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors.
    Dalba C; Klatzmann D; Logg CR; Kasahara N
    Curr Gene Ther; 2005 Dec; 5(6):655-67. PubMed ID: 16457654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
    Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO
    Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors.
    Logg CR; Tai CK; Logg A; Anderson WF; Kasahara N
    Hum Gene Ther; 2001 May; 12(8):921-32. PubMed ID: 11387057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication-competent retrovirus vectors for cancer gene therapy.
    Tai CK; Kasahara N
    Front Biosci; 2008 Jan; 13():3083-95. PubMed ID: 17981778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector.
    Takahashi M; Valdes G; Hiraoka K; Inagaki A; Kamijima S; Micewicz E; Gruber HE; Robbins JM; Jolly DJ; McBride WH; Iwamoto KS; Kasahara N
    Cancer Gene Ther; 2014 Oct; 21(10):405-410. PubMed ID: 25301172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-retrovirus hybrid vectors achieve highly enhanced tumor transduction and antitumor efficacy in vivo.
    Kubo S; Haga K; Tamamoto A; Palmer DJ; Ng P; Okamura H; Kasahara N
    Mol Ther; 2011 Jan; 19(1):76-82. PubMed ID: 20808291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.